BioAffinity Technologies Inc (NASDAQ: BIAF) Disappoints Wall Street With -7.79% Stock Price Drop

In the latest trading session, 2.95 million BioAffinity Technologies Inc (NASDAQ:BIAF) shares changed hands as the company’s beta touched 3.01. With the company’s most recent per share price at $0.75 changed hands at -$0.06 or -7.79% at last look, the market valuation stands at $11.64M. BIAF’s current price is a discount, trading about -382.67% off its 52-week high of $3.62. The share price had its 52-week low at $0.80, which suggests the last value was -6.67% down since then. When we look at BioAffinity Technologies Inc’s average trading volume, we note the 10-day average is 0.11 million shares, with the 3-month average coming to 154.58K.

BioAffinity Technologies Inc (NASDAQ:BIAF) trade information

Instantly BIAF was in red as seen in intraday trades today. With action -20.54%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -17.92%, with the 5-day performance at -20.54% in the red. However, in the 30-day time frame, BioAffinity Technologies Inc (NASDAQ:BIAF) is -23.00% down. Looking at the short shares, we see there were 0.27 million shares sold at short interest cover period of 1.43 days.

BioAffinity Technologies Inc (BIAF) estimates and forecasts

Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 2.42M. 1 analysts are of the opinion that BioAffinity Technologies Inc’s revenue for the current quarter will be 2.62M.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -19.28%. The 2025 estimates are for BioAffinity Technologies Inc earnings to increase by 24.18%.

BIAF Dividends

BioAffinity Technologies Inc is expected to release its next quarterly earnings report in February.

BioAffinity Technologies Inc (NASDAQ:BIAF)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 29.55% of BioAffinity Technologies Inc shares while 3.03% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.29%.

Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund. With 220.23 shares estimated at $0.16 million under it, the former controlled 1.41% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.30% of the shares, roughly 47.0 shares worth around $34490.0.